Silver nanoparticle and polyurethane composite provides potential coating options to limit fomite transmission of SARS-CoV-2

In a recent study published in Polymers, researchers synthesized and evaluated a silver and polyurethane nanocomposite surface coating material that exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Study: Synthesis and Evaluation of a Silver Nanoparticle/Polyurethane Composite That Exhibits Antiviral Activity against SARS-CoV-2. Image Credit: CKA/Shutterstock
Study: Synthesis and Evaluation of a Silver Nanoparticle/Polyurethane Composite That Exhibits Antiviral Activity against SARS-CoV-2. Image Credit: CKA/Shutterstock

Background

During the initial stages of the coronavirus disease 2019 (COVID-19), when the route of transmission of SARS-CoV-2 was thought to be primarily through fomites, surface sanitization with disinfectants and sanitizers was widely recommended. Although studies have now shown that the primary mode of viral transmission is through aerosolized droplets expelled through coughing, sneezing, and talking, it is believed that contaminated surfaces do play a role in the spread of the virus.

Many heavy metals and metal oxides such as magnesium, zinc, and copper are known to exhibit antiviral properties, and nanoparticles of these metals have been used to reduce the persistence of viruses on surfaces. Silver nanoparticles coated onto fabrics and used in face masks have been seen to reduce viral loads.

Metal nanoparticles are combined with polymers to form nanocomposite polymers that exhibit antimicrobial properties. A silver nanoparticle composite polymer that can be used to coat preinstalled touchpoints could provide self-sanitizing surfaces without the need to replace existing fixtures.

About the study

In the present study, the researchers used morpholine-terminated polyurethane as the continuous phase to build the nanocomposite, since they form tough films, and the starting materials to form the polyurethanes are inexpensive. Oligomeric diol components are polymerized with diisocyanates to synthesize polyurethane, and its physical properties can be modulated by altering the diol or diisocyanate structure or adding an end group.

KrasolTM HLBH-P2000 and 4,4′-methylene diphenyl diisocyanate were the diol and diisocyanate components, respectively, in morpholine terminated polyurethane, and 4-(2-aminoethyl) morpholine was the end group. Nuclear magnetic resonance (NMR) spectroscopy and size exclusion chromatography (SEC) were used to characterize the polyurethane.

The nanocomposite was formed by adding silver nanoparticles to polyurethane dissolved in anhydrous tetrahydrofuran to cast films of uniform thickness. The film was then heated at 50 °C and 800 mbar in a vacuum oven and allowed to cool. Fourier transform infrared spectroscopy (FTIR) was used to determine the reactivity of the nanocomposite.

The films were sterilized using ethanol and ultraviolet light. HEK293T cells with stable expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2), and pseudotyped viruses expressing the SARS-CoV-2 Beta spike protein were used to test the antiviral activity of the films.

Results

The results indicated that the addition of 10 wt.% silver nanoparticles to the morpholine-terminated polyurethane formed robust composite films. The silver nanoparticles also increased the tensile strength, and the toughness and elasticity moduli of the polyurethane.

The NMR spectrum contained well-resolved signals for all the expected structural features of the polyurethane. The SEC results revealed a number averaged molecular weight of 8700 g/mol and weight averaged molecular weight of 15,400 g/mol. The FTIR spectrum did not indicate unreactive isocyanate and showed interactions between the silver nanoparticles and the NH and carbonyl groups of the polyurethane.

Mechanical testing determined that the silver polyurethane nanocomposite had higher tensile and toughness moduli and ultimate tensile strength than the morpholine-terminated polyurethane but had lower elongation at break. However, since the material was being developed for coating fixtures and touchpoints, elongation at break was not an important requirement.

The biological testing revealed a 67% reduction in the viable viral amount by the nanocomposite after 24 hours with no human intervention, compared to polyurethane without silver nanoparticles.

Conclusions

To conclude, the researchers developed and tested a silver nanoparticle polyurethane composite to develop a self-sanitizing, antiviral material to coat touchpoints. The results revealed that the silver nanoparticles exhibited significant antiviral activity and increased the ultimate tensile strength and the tensile and toughness moduli of the polyurethane.

Polyurethanes often form the base in many commercial coatings and paints. This study provides a viable option to provide existing fixtures and surfaces such as door handles with an antimicrobial coating, instead of having to replace them with copper or other antimicrobial metal fixtures. Though SARS-CoV-2 is now known to spread less through fomites than through direct aerosolized particles, this nanocomposite can be used to control transmission in the early stages of future pandemics before vaccines and therapeutic methods are developed.

Journal reference:
Dr. Chinta Sidharthan

Written by

Dr. Chinta Sidharthan

Chinta Sidharthan is a writer based in Bangalore, India. Her academic background is in evolutionary biology and genetics, and she has extensive experience in scientific research, teaching, science writing, and herpetology. Chinta holds a Ph.D. in evolutionary biology from the Indian Institute of Science and is passionate about science education, writing, animals, wildlife, and conservation. For her doctoral research, she explored the origins and diversification of blindsnakes in India, as a part of which she did extensive fieldwork in the jungles of southern India. She has received the Canadian Governor General’s bronze medal and Bangalore University gold medal for academic excellence and published her research in high-impact journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sidharthan, Chinta. (2022, October 07). Silver nanoparticle and polyurethane composite provides potential coating options to limit fomite transmission of SARS-CoV-2. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20221007/Silver-nanoparticle-and-polyurethane-composite-provides-potential-coating-options-to-limit-fomite-transmission-of-SARS-CoV-2.aspx.

  • MLA

    Sidharthan, Chinta. "Silver nanoparticle and polyurethane composite provides potential coating options to limit fomite transmission of SARS-CoV-2". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20221007/Silver-nanoparticle-and-polyurethane-composite-provides-potential-coating-options-to-limit-fomite-transmission-of-SARS-CoV-2.aspx>.

  • Chicago

    Sidharthan, Chinta. "Silver nanoparticle and polyurethane composite provides potential coating options to limit fomite transmission of SARS-CoV-2". News-Medical. https://www.news-medical.net/news/20221007/Silver-nanoparticle-and-polyurethane-composite-provides-potential-coating-options-to-limit-fomite-transmission-of-SARS-CoV-2.aspx. (accessed November 22, 2024).

  • Harvard

    Sidharthan, Chinta. 2022. Silver nanoparticle and polyurethane composite provides potential coating options to limit fomite transmission of SARS-CoV-2. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20221007/Silver-nanoparticle-and-polyurethane-composite-provides-potential-coating-options-to-limit-fomite-transmission-of-SARS-CoV-2.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients